We are a clinical stage oncology therapeutics company developing a paradigm shift in regards to the treatment of cancer

  • Lead Product Candidate – OLX01, is entering Phase II clinical development for pancreatic cancer.

  • Ongoing Product Development – Pipeline of drug candidates targeting NSCL, ovarian and colorectal.

  • Treatment Efficacy – Targeting metabolic dysfunction avoids the pitfalls of the broad toxicity of platinum-based therapies, enhances the cancer cells sensitivity to chemotherapy & immunotherapy and enhances p53 mediated cellular apoptosis in cancer cells.

  • Experienced Leadership – 100 years of combined pharma experience and 20 products commercialized.

  • Performance History – Over 1,200 patients safely and effectively treated.

The Problem – Targeting cancers with high mortality and limited treatment options

Meet Our Team

Michael HandleyCEO
Successful pharmaceutical executive with over 17 products commercialized and two successful exits in excess of $1.2B. Both public and private company experience.
Andy WhiteCFO
Over 20 years of experience in the healthcare and biomedical industries. Experience includes management of health system contracts, cardio-pulmonary products, orthopedic products, SaaS software, and biopharmaceuticals.
Scott Dunbar M.D.Medical Advisor
Successful Dartmouth trained medical oncologist and hematologist with over 16 years of clinical practice experience. Helped to grow the largest privately held oncology practice in the US.
Victoria Headley J.D. LLMLegal Advisor
An accomplished senior corporate counsel with significant experience handling corporate, transaction and intellectual property matters both domestically and internationally. Also possesses three law degrees and extensive experience in the healthcare sector.
Jim CarlsonChief Regulatory Director
Need Bio

Meet Our Board of Directors

Peter LangeDirector
Need Bio
Michael VolkDirector
Need Bio
Brian DenommeDirector
Need Bio
Andy WhiteCFO
Over 20 years of experience in the healthcare and biomedical industries. Experience includes management of health system contracts, cardio-pulmonary products, orthopedic products, SaaS software, and biopharmaceuticals.

“We are constantly discovering and innovating to make a meaningful impact for the patients we serve. We are pushing the boundaries on what science and technology can do, making the impossible, possible.”

PETER LANGE, DIRECTOR

OLX01

Put a brief description here

Our Solution

Put a brief description here

Product Pipeline

Put a brief description here

About Us

Put a brief description here